• Profile
Close
Sign Up / Log In
Journal Summaries
Gastroenterology
  GI Infectious Disease

Preoperative treatment of Hepatitis C is associated with lower prosthetic joint infection rates in US Veterans

Journal of Arthroplasty | Mar 15, 2019 GI Infectious Disease

Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort study

Journal of Viral Hepatitis | Mar 14, 2019 GI Infectious Disease

Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection

Cytokine | Mar 14, 2019 GI Infectious Disease

Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: Real-life experiences

European Journal of Gastroenterology & Hepatology | Mar 10, 2019 GI Infectious Disease

Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin

European Journal of Gastroenterology & Hepatology | Mar 10, 2019 GI Infectious Disease

Impact of direct-acting antivirals on leukocytic DNA telomere length in hepatitis C virus-related hepatic cirrhosis

European Journal of Gastroenterology & Hepatology | Mar 09, 2019 GI Infectious Disease

Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients

European Journal of Gastroenterology & Hepatology | Mar 09, 2019 GI Infectious Disease

Risk of bacterial pneumonia and pneumococcal infection in youths with celiac disease — A population-based study

Digestive and Liver Diseases | Mar 07, 2019 GI Infectious Disease

Cadazolid for the treatment of Clostridium difficile infection: Results of two double-blind, placebo-controlled, non-inferiority, randomized phase 3 trials

The Lancet Infectious Diseases | Mar 06, 2019 GI Infectious Disease

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): A randomised, placebo controlled, phase 2 trial

The Lancet Infectious Diseases | Mar 05, 2019 GI Infectious Disease

1 … 30 32 34 … 80
Most read this week
1

BRI or BMI: What is More Efficient?
Placeholder
2

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions
Placeholder
3

These Popular Snacks Linked a Decline in Mental Health
Placeholder
4

Awareness for COPD: MCQ challenge
Placeholder
5

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies
Placeholder
Bannerimg

A variety of information related to Medicine and Health Care. It's all here.

x
M3 app logo
Choose easy access to M3 India from your mobile!

Add to home

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay